Literature DB >> 23180259

Risk-benefit analysis: from a logical point of view.

Georg Spielthenner1.   

Abstract

In this paper I am concerned with risk-benefit analysis; that is, the comparison of the risks of a situation to its related benefits. We all face such situations in our daily lives and they are very common in medicine too, where risk-benefit analysis has become an important tool for rational decision-making. This paper explores risk-benefit analysis from a logical point of view. In particular, it seeks a better understanding of the common view that decisions should be made by weighing risks against benefits and that an option should be chosen if its benefits outweigh its risks. I devote a good deal of this paper scrutinizing this popular view. Specifically, I demonstrate that this mode of reasoning is logically faulty if "risk" and "benefit" are taken in their absolute sense. But I also show that arguing in favour of an action because its benefits outweigh its risks can be valid if we refer to incremental risks and benefits.

Mesh:

Year:  2012        PMID: 23180259     DOI: 10.1007/s11673-012-9366-y

Source DB:  PubMed          Journal:  J Bioeth Inq        ISSN: 1176-7529            Impact factor:   1.352


  22 in total

1.  The future of research into rotavirus vaccine.

Authors:  C Weijer
Journal:  BMJ       Date:  2000-09-02

2.  Risk: benefit ratio is important in treating atopic dermatitis.

Authors:  B Roger Allen; Thomas A Luger
Journal:  BMJ       Date:  2002-10-26

3.  Explaining public resistance to genetically modified corn: an analysis of the distribution of benefits and risks.

Authors:  Felicia Wu
Journal:  Risk Anal       Date:  2004-06       Impact factor: 4.000

4.  Declaration of Helsinki. Ethical principles for medical research involving human subjects.

Authors: 
Journal:  J Indian Med Assoc       Date:  2009-06

5.  Hormone replacement therapy again. Risk-benefit relation differs between populations and individuals.

Authors:  K T Khaw
Journal:  BMJ       Date:  1998-06-20

Review 6.  Stopping trials early for commercial reasons: the risk-benefit relationship as a moral compass.

Authors:  A S Iltis
Journal:  J Med Ethics       Date:  2005-07       Impact factor: 2.903

Review 7.  Anticoagulant drugs in the elderly: the risks usually outweight the benefits.

Authors:  P J Scott
Journal:  BMJ       Date:  1988-11-12

8.  A public health perspective on research ethics.

Authors:  D R Buchanan; F G Miller
Journal:  J Med Ethics       Date:  2006-12       Impact factor: 2.903

9.  Risk and medical ethics.

Authors:  E Pochin
Journal:  J Med Ethics       Date:  1982-12       Impact factor: 2.903

Review 10.  Balancing the risks and benefits of moderate drinking.

Authors:  R Curtis Ellison
Journal:  Ann N Y Acad Sci       Date:  2002-05       Impact factor: 5.691

View more
  1 in total

1.  Signposts in a familiar land?: a second (or third or fourth…) look at lingering bioethical concerns.

Authors:  Michael A Ashby; Leigh E Rich
Journal:  J Bioeth Inq       Date:  2012-06       Impact factor: 1.352

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.